CA
NZ
UK
AU
IND
US
Health Catalyst, Inc. (NASDAQ: HCAT) has repaid its debt after selling its Vitalware business for $147 million. The company used the proceeds from the sale, along with cash on hand, to repay its outstanding debt. This move is expected to improve the company's financial …
BioLife Solutions (NASDAQ: BLFS) delivered Q2 earnings per share of $0.04, surpassing the $0.03 consensus figure, while revenue climbed 21% to $28.5 million. GAAP net income surged to $45.1 million, buoyed by a $42.4 million non‑cash tax benefit, and adjusted EBITDA hit $7.4 million, …
Concentra Group Holdings Parent, Inc. (NYSE: CON) posted second‑quarter earnings per share of $0.52, eclipsing the $0.42 consensus estimate, while revenue climbed 10.0% to $606.0 million. Net income surged 45.7% to $67.3 million, and Adjusted EBITDA rose 22.5% to $140.9 million. Investors gain confidence …
Definium Therapeutics (NASDAQ: DFTX) posted a quarterly earnings per share of $-1.44, sharply missing the $-0.56 consensus estimate, while its cash, cash equivalents and investments climbed to approximately $1.1 billion, more than double the $411.6 million balance at the end of 2025. The cash …
Eli Lilly's second-quarter revenue surged 48% year over year, reaching $23 billion, driven by booming sales of obesity treatments like Mounjaro and Zepbound. This performance prompted the company to raise its full-year revenue guidance to between $85 billion and $87 billion, indicating strong growth …
Guardian Pharmacy Services (NYSE: GRDN) posted earnings per share of $0.29 for the quarter ended June 30, comfortably beating the $0.28 consensus. Investors see the beat as a sign that the company’s growth engine remains intact while it broadens its geographic reach.
Inogen Inc (NASDAQ: INGN) achieved $95.1 million in revenue for the second quarter ending June 30, 2026, marking a 3% increase from $92.3 million during the same period last year. This growth comes as the company's earnings per share aligned positively, reporting at $-0.14 …
Alector, Inc. (NASDAQ: ALEC) reported a second-quarter net loss of $23 million, translating to $0.21 per share, marking a significant decrease from the $30.5 million loss recorded in the same quarter last year. This improvement highlights Alector's ongoing strategy to streamline operations while progressing …
ElectroCore, Inc. (NASDAQ: ECOR) reported a strong second quarter, achieving revenue of $9.5 million, which marks a significant 28% increase from $7.4 million in the same quarter last year. This performance surpassed analysts' expectations, as the company recorded an EPS of $-0.33, better than …
Globus Medical Inc (NYSE: GMED) reports a 5.9% increase in revenue to $789.6 million, driven by strong sales growth in its US and International Spine segments. The company's non-GAAP diluted EPS jumps 55.8% to $1.34, beating consensus estimates of $1.12. As the company continues …
Please wait processing your request...